Dr. Ali Almedhychy is a cardiologist, inventor and entrepreneur with 15 years of experience in senior medical and scientific positions; he is currently the Medical Director of Cordis (a Cardinal Health Company).
At Cordis, Dr. Almedhychy oversees the Medical Affairs departments, where he manages teams with scientific rigor and a deep understanding of medical ethics, compliance, and regulations. The Cordis Medical Affairs department transforms data into practical insights, improve real-world medical decisions, and create value to patients and physicians.
Dr. Almedhychy’s recent corporate career included Founder & Chief Scientific Officer of Catharos Medical Systems (a clinical-stage start-up combating contrast-induced nephropathy), and Medical Director at Access Closure (the maker of the Mynx vascular closure device, acquired by Cardinal Health).
Dr. Almedhychy’s maintains a visiting scholar affiliation at Stanford University (Palo Alto, California), and participates as faculty in scientific conferences, with thorough insight in medical, science, and industry trends that provides Cardinal Health with a competitive edge. Dr. Almedhychy’s research background involves cardiovascular disease and transcatheter methods and devices. Dr. Almedhychy has over 60 publications and 18 patent families in the field of cardiovascular medicine; he also acted as a clinical investigator in large, multi-center clinical trials.
Dr. Almedhychy completed his medical studies and training in Austria (Europe), and Cardiology fellowship at Stanford University.